Citation, commencement, extent and application

1.—(1 ) These Regulations may be cited as the Health Protection (Notification) (Amendment) Regulations 2025.

(2) These Regulations come into force on 6th April 2025.

(3) These Regulations extend to England and Wales and apply in relation to England only.

Amendment to the Health Protection (Notification) Regulations 2010

2.The Health Protection (Notification) Regulations 2010(2) are amended in accordance with regulations 3 to 5.

Amendment of regulation 4

3. In regulation 4 (duty on the operators of diagnostic laboratories to notify the United Kingdom Health Security Agency of causative agents found in human samples and of SARS-CoV-2 or influenza virus tests processed)—

(a)in the heading, after “SARS-CoV-2” insert “, respiratory syncytial virus”;

(b)in paragraph (1A)(b), after “of” insert “respiratory syncytial virus or”;

(c)in paragraph (2)(ba), after “SARS-CoV-2” insert “, respiratory syncytial virus”.

Amendment of Schedule 1

4. In Schedule 1 (Notifiable Diseases), at the appropriate alphabetical place insert—

• Acute flaccid paralysis or acute flaccid myelitis (AFP or AFM)

• Chickenpox (varicella)

• Congenital syphilis

• Creutzfeldt-Jakob disease (CJD)

• Disseminated gonococcal infection (DGI)

• Influenza of zoonotic origin

• Middle East respiratory syndrome coronavirus (MERS)

• Neonatal herpes

Amendment of Schedule 2

5. In Schedule 2 (Causative Agents), at the appropriate alphabetical place insert—

• Candidozyma auris

• Echinococcus spp

• Middle East respiratory syndrome coronavirus (MERS-CoV)

• Non-human influenza A subtypes

• Norovirus

• Respiratory syncytial virus (RSV)

• Tick-borne encephalitis virus (TBEV)

• Toxoplasma (congenital toxoplasmosis)

• Trichinella spp

• Yersinia spp